In this Episode, Joel Latham, CEO of Incannex Healthcare, discusses his career journey, the innovative approaches of Incannex Healthcare in drug development, particularly focusing on combination therapies involving cannabinoids and psychedelics. He highlights the company's unique solutions for obstructive sleep apnea and other chronic conditions, emphasizing the importance of patient-centric approaches and the potential for significant market impact. Latham also shares insights into the future vision of Incannex Healthcare and the expected advancements in their lead assets.INCANNEX WEBSITE: https://incannex.com/NANO CAP PODCAST WEBSITE: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Ver todos los episodios